TrialPloS one2015

24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial.

Qingxian Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.